| scholarly article | Q13442814 |
| P2093 | author name string | Abiola C Senok | |
| P2860 | cites work | Potential uses of probiotics in clinical practice | Q24681377 |
| Probiotics--compensation for lactase insufficiency | Q28142673 | ||
| Health claim evidence requirements in Japan. | Q30369507 | ||
| Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. | Q30822615 | ||
| Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. | Q33711137 | ||
| Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. | Q33989292 | ||
| Taxonomy and important features of probiotic microorganisms in food and nutrition | Q34130889 | ||
| Probiotics and safety | Q34130960 | ||
| Market potential for probiotics | Q34130970 | ||
| Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro | Q34522706 | ||
| Probiotics: facts and myths | Q36322211 | ||
| Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend? | Q37094595 | ||
| Health claims in Europe: new legislation and PASSCLAIM for substantiation | Q37168833 | ||
| Health claims in the United States: an aid to the public or a source of confusion? | Q37168838 | ||
| Identification and characterization of starter lactic acid bacteria and probiotics from Columbian dairy products. | Q40090651 | ||
| Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine | Q44514648 | ||
| US Food and Drug Administration regulations governing label claims for food products, including probiotics | Q44935060 | ||
| Health-benefit claims for probiotic products | Q44935064 | ||
| Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa | Q46805257 | ||
| Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis | Q54656417 | ||
| Identification of probiotic microorganisms in South African products using PCR-based DGGE analysis. | Q54687881 | ||
| Survival of Lactobacillus helveticus entrapped in Ca-alginate in relation to water content, storage and rehydration | Q73050798 | ||
| Effects of ingestion of yogurts containing Bifidobacterium and Lactobacillus acidophilus on spleen and Peyer's patch lymphocyte populations in the mouse | Q73624808 | ||
| Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice | Q77354483 | ||
| Microbiologic evaluation of commercial probiotics | Q77833371 | ||
| Current marketplace for probiotics: a Japanese perspective | Q80463726 | ||
| Numbers and strains of lactobacilli in some probiotic products | Q80997390 | ||
| P921 | main subject | probiotics | Q1816730 |
| P577 | publication date | 2009-03-04 | |
| P1433 | published in | Food Nutrition Research | Q15761874 |
| P1476 | title | Probiotics in the arabian gulf region | |
| P478 | volume | 53 |
| Q42119743 | Antimicrobial activity and the presence of virulence factors and bacteriocin structural genes in Enterococcus faecium CM33 isolated from ewe colostrum | cites work | P2860 |
Search more.